Divis lab results q4 2021

Divi's Labs soars 4.

Mutual Funds. ET TV. More Menu. Earnings season ends today. All News Videos.

Divis lab results q4 2021

Choose your reason below and click on the Report button. This will alert our moderators to take action. Log out of your current logged-in account and log in again using your ET Prime credentials to enjoy all member benefits. Stock analysis. Market Research. Nifty 22, Precious Metal. Mutual Funds. ET TV. More Menu.

Live Blog. Annual Report

Divi's Labs soars 4. Divi's Labs Q2 Preview: Earnings likely to improve sequentially on better margins, product mix. Divi's Labs Q1 Preview: Base effect to pressure earnings, brokerages predict sequential recovery. Divi's Labs Preview: Unfavourable base, elevated input costs to turn Q4 a sour pill. India Inc Q2 review: Earnings breadth deteriorates; margin pressure stark. Q3 earnings: Nirmal Bang reviews Glenmark, Divi's results. Pharma Q3: New launches, generic drug demand to aid growth.

Choose your reason below and click on the Report button. This will alert our moderators to take action. Log out of your current logged-in account and log in again using your ET Prime credentials to enjoy all member benefits. Stock analysis. Market Research. Nifty 22, Precious Metal. Mutual Funds. ET TV.

Divis lab results q4 2021

The Group considered the uncertainty relating to the COVID pandemic in assessing the recoverability of its inventories, receivables and investments. As the Group is into essential manufacturing service, which is exempt from lockdown restrictions, the pandemic did not have any significant impact in its operations or its supply chain, the company added. A part of the project has been completed and became operational and the rest of the capex will be completed during early part of the next financial year. Milestone Alert! Unlock a world of Benefits! From insightful newsletters to real-time stock tracking, breaking news and a personalized newsfeed — it's all here, just a click away! Login Now! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.

Lugares para tatuarse letras

Divi's Labs Q2 Preview: Earnings likely to improve sequentially on better margins, product mix. Open Interest 39,43, , This will alert our moderators to take action Name Reason for reporting: Foul language Slanderous Inciting hatred against a certain community Others. Divis Labs Stock Performance. Pick the best stocks for yourself. Mutual Funds. L Kishore Babu, Mr. NSE Live Mar 07, As per Refinitiv erstwhile Thomson Reuters , overall mean recommendation by 20 analysts for Divis Labs stock is to Sell. Fill in your details: Will be displayed Will not be displayed Will be displayed. Choose your reason below and click on the Report button. More Menu. S Ganapaty, Prof. Investment Ideas. Markets Data.

Pharma company, Divi's Labs registered feeble Q4 earnings.

These 5 Nifty50 stocks are likely to post double-digit profit fall in Q4. PB Ratio x. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. Company has reported net profit after tax of Rs Divis Labs share price insights Topline Contraction Sales de-grew by Face Value. Find this comment offensive? Exclusive Student Only Offer. ET TV. Portfolio Watchlist. Join Us On. Cryptocurrency Crypto News. S Ganapaty, Prof. The profit was below the ET Now poll estimate of Rs crore.